TBIO - Telesis Bio appoints William Kullback as CFO
2023-08-29 16:19:04 ET
More on Codex DNA
- BofA lowers rating on Telesis Bio to sector weight from overweight
- Telesis Bio gets $28 million in financing through preferred stock private placement
- Despite 22% gain today, Codex DNA still well down from June IPO price
- Pfizer in pact with Codex DNA to develop mRNA-based vaccines and biotherapies
- Seeking Alpha’s Quant Rating on Codex DNA
- Earnings data for Codex DNA
For further details see:
Telesis Bio appoints William Kullback as CFO